Literature DB >> 21495119

Synthesis, preferred conformation, protease stability, and membrane activity of heptaibin, a medium-length peptaibiotic.

Marta De Zotti1, Barbara Biondi, Cristina Peggion, Yoonkyung Park, Kyung-Soo Hahm, Fernando Formaggio, Claudio Toniolo.   

Abstract

The medium-length peptaibiotics are characterized by a primary structure of 14-16 amino acid residues. Despite the interesting antibiotic and antifungal properties exhibited by these membrane-active peptides, their exact mechanism of action is still unknown. Here, we present our results on heptaibin, a 14-amino acid peptaibiotic found to exhibit antimicrobial activity against Staphylococcus aureus. We carried out the very challenging synthesis of heptaibin on solid phase and a detailed conformational analysis in solution. The peptaibiotic is folded in a mixed 3₁₀-/α-helix conformation which exhibits a remarkable amphiphilic character. We also find that it is highly stable toward degradation by proteolytic enzymes and nonhemolytic. Finally, fluorescence leakage experiments using small unilamellar vesicles of three different compositions revealed that heptaibin, although uncharged, is a selective compound for permeabilization of model membranes mimicking the overall negatively charged surface of Gram-positive bacteria. This latter finding is in agreement with the originally published antimicrobial activity data.
Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21495119     DOI: 10.1002/psc.1364

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  3 in total

1.  Targeting the cyclin-binding groove site to inhibit the catalytic activity of CDK2/cyclin A complex using p27(KIP1)-derived peptidomimetic inhibitors.

Authors:  Arumugasamy Karthiga; Sunil Kumar Tripathi; Ramasamy Shanmugam; Venkatesan Suryanarayanan; Sanjeev Kumar Singh
Journal:  J Chem Biol       Date:  2014-09-18

2.  Comparison of bactericidal and cytotoxic activities of trichogin analogs.

Authors:  Regina Tavano; Giulia Malachin; Marta De Zotti; Cristina Peggion; Barbara Biondi; Fernando Formaggio; Emanuele Papini
Journal:  Data Brief       Date:  2015-12-17

3.  The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach.

Authors:  Annalisa Dalzini; Christian Bergamini; Barbara Biondi; Marta De Zotti; Giacomo Panighel; Romana Fato; Cristina Peggion; Marco Bortolus; Anna Lisa Maniero
Journal:  Sci Rep       Date:  2016-04-04       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.